Cenicriviroc: latest news - GoINPHARMA
Friday, 22 March 2019 - 1:20


NASH: new results from Allergan’s drug

Allergan announced new data from the CENTAUR Phase IIb study which supports the anti-fibrotic efficacy and safety of Cenicriviroc (CVC) for the treatment of liver fibrosis in adults with NASH. The results from a one-year treatment with cenicriviroc were released…